Rolke James 4
4 · REVELATION BIOSCIENCES, INC. · Filed Oct 31, 2025
Insider Transaction Report
Form 4
Rolke James
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-10-29$1.28/sh+390,614$499,986→ 400,660 total
Holdings
- 10,046
Common Stock
Footnotes (1)
- [F1]Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests quarterly over one year from the grant date.